The story of Viagra, originally marketed by copyright, presents a fascinating case study for stakeholders considering the healthcare sector. Although its groundbreaking success and impact of billions in earnings , the intellectual property expiration has opened the floodgates for competing medications, greatly diminishing income opportunities. This